Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients  Maurizio Postorino, Carmen.

Slides:



Advertisements
Similar presentations
Table S1. Logistic regression analysis for the variables associated with the degree of change in cTnT between 2 time points (n=89) UnivariateMultivariate.
Advertisements

Volume 82, Issue 12, Pages (December 2012)
Vitamin D levels and patient outcome in chronic kidney disease
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2009 American Medical Association. All rights reserved.
Linear and logistic regression analysis
Adjusted all-cause mortality risk by dialysate sodium (DNa) and predialysis serum sodium (SNa). Adjusted all-cause mortality risk by dialysate sodium (DNa)
Volume 375, Issue 9709, Pages (January 2010)
Volume 87, Issue 5, Pages (May 2015)
Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:
C-reactive protein and dialysis access
Gudrun Hatlen, Solfrid Romundstad, Stein I. Hallan 
The risk of hospitalization and modality failure with home dialysis
Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.
Volume 80, Issue 1, Pages (July 2011)
C-reactive protein and dialysis access
Volume 82, Issue 12, Pages (December 2012)
Volume 54, Issue 2, Pages (August 1998)
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies 
Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease  Jessica Kendrick,
Volume 86, Issue 4, Pages (October 2014)
Volume 88, Issue 2, Pages (August 2015)
Volume 379, Issue 9822, Pages (March 2012)
Joel D. Kopple, Xiaofei Zhu, Nancy L. Lew, Edmund G. Lowrie 
Volume 79, Pages S9-S13 (April 2011)
Volume 79, Issue 12, Pages (June 2011)
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
Volume 87, Issue 6, Pages (June 2015)
Volume 63, Issue 3, Pages (March 2003)
Volume 68, Issue 6, Pages (December 2005)
Volume 76, Issue 10, Pages (November 2009)
Volume 56, Issue 2, Pages (August 1999)
Volume 84, Issue 5, Pages (November 2013)
The online measurement of hemodialysis dose (Kt): Clinical outcome as a function of body surface area  Edmund G. Lowrie, Zhensheng Li, Norma Ofsthun,
Volume 67, Issue 6, Pages (June 2005)
Survival advantage in Asian American end-stage renal disease patients1
Volume 77, Issue 7, Pages (April 2010)
Volume 79, Issue 9, Pages (May 2011)
Stephen P. McDonald  Kidney International Supplements 
Jennifer E. Flythe, Stephen E. Kimmel, Steven M. Brunelli 
U-shaped effect of eGFR and mortality
Body size and outcomes on peritoneal dialysis in the United States
Volume 379, Issue 9822, Pages (March 2012)
The dynamics of prognostic indicators: toward earlier identification of dialysis patients with a high risk of dying  Charles Chazot, Guillaume Jean  Kidney.
Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.
Vitamin D levels and patient outcome in chronic kidney disease
Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower 
Volume 71, Issue 6, Pages (March 2007)
Volume 76, Issue 9, Pages (November 2009)
Volume 80, Issue 6, Pages (September 2011)
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease  C.P. Kovesdy, S. Ahmadzadeh,
Volume 79, Issue 2, Pages (January 2011)
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Volume 73, Issue 8, Pages (April 2008)
Volume 84, Issue 4, Pages (October 2013)
Volume 82, Issue 3, Pages (August 2012)
Volume 74, Issue 8, Pages (October 2008)
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1  Robert N. Foley, Charles A. Herzog, Allan J.
Carmine Zoccali, Francesca Mallamaci  Kidney International 
Volume 61, Issue 2, Pages (February 2002)
Volume 80, Issue 10, Pages (November 2011)
Volume 75, Issue 1, Pages (January 2009)
Is There an “Asymptote of Gain” Beyond Which Further Increases in Cardiorespiratory Fitness Convey No Additional Benefits on Mortality and Atrial Fibrillation? 
Volume 75, Issue 7, Pages (April 2009)
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Volume 61, Issue 2, Pages (February 2002)
Volume 76, Issue 5, Pages (September 2009)
Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients  M.R. Marshall, B.G. Byrne, P.G. Kerr,
Friends, social networks, and progressive chronic kidney disease
Among three residual kidney function (RKF) indices, only residual urine volume (UV) indicated an independent prognostic value in patients with UV≥0.1 or.
Presentation transcript:

Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients  Maurizio Postorino, Carmen Marino, Giovanni Tripepi, Carmine Zoccali  Kidney International  Volume 79, Issue 7, Pages 765-772 (April 2011) DOI: 10.1038/ki.2010.493 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Incidence rate of all-cause and cardiovascular mortality throughout triglyceride levels separately in patients in the third (gray circles) and in the first/second (white circles) waist circumference tertiles (see Results section for more details). Kidney International 2011 79, 765-772DOI: (10.1038/ki.2010.493) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Hazard ratios (HRs) and 95% confidence intervals for all-cause and cardiovascular mortality of a fixed (50mg/dl) excess in serum triglycerides across waist circumference values. As shown in the figure, the HR of serum triglycerides was neutral (HR∼1) when the waist circumference was 95cm. Furthermore, a fixed (50mg/dl) excess in triglycerides was associated with a gradual decrease in the risk of all-cause and cardiovascular (CV) mortality at progressively lower levels of waist circumference in patients with a waist circumference <95cm but with an opposite effect in those with waist circumference >95. The HRs were adjusted for the full set of variables listed in Table 2. The effect modification of waist circumference on the prognostic effect of serum triglycerides was also almost identical after the exclusion of the outlier (waist circumference: 172cm; triglycerides: 418mg/dl; total cholesterol: 175mg/dl; see Results section for more details). Kidney International 2011 79, 765-772DOI: (10.1038/ki.2010.493) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 Hazard ratios (HRs) and 95% confidence intervals for all-cause and cardiovascular mortality of a fixed (50mg/dl) excess in serum cholesterol across waist circumference values. As shown in the figure, the hazard ratio of serum cholesterol was neutral (HR∼1) when the waist circumference was 95cm. Furthermore, a fixed (50mg/dl) excess in cholesterol was associated with a gradual decrease in the risk of all-cause and CV mortality at progressively lower levels of waist circumference in patients with a waist circumference <95cm, but with an opposite effect in those with waist circumference >95cm. The HRs were adjusted for all potential confounders (all-cause mortality model: cholesterol, waist circumference, cholesterol/waist circumference interaction term, body mass index (BMI), age, smoking, diabetes, hemoglobin, dialysis vintage, and C-reactive protein (CRP); cardiovascular (CV) mortality model: cholesterol, waist circumference, cholesterol/waist circumference interaction term, BMI, age, smoking, diabetes, fractional urea clearance (urea clearance×time/volume), dialysis vintage, treatment with statins/polyunsaturated omega-3 fatty acids supplements, and CRP). The effect modification of waist circumference on the prognostic effect of serum cholesterol was also almost identical after the exclusion of the outlier (waist circumference: 172cm; triglycerides: 418mg/dl; total cholesterol: 175mg/dl; see Results section for more details). Kidney International 2011 79, 765-772DOI: (10.1038/ki.2010.493) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 4 Estimated probabilities of all-cause and cardiovascular (CV) death associated with progressively higher values of serum triglycerides according to waist circumference tertiles. These probabilities were calculated by using the regression coefficients of Cox regression analyses, adjusting for all variables listed in Table 2. In these categorical analyses, progressively higher levels of triglycerides had opposite associations with clinical outcomes in the first (increasing risk at lower waist circumference) and in the third (increasing risk at higher waist circumference) tertile of waist circumference. In the middle waist circumference tertile, a progressive increase in triglycerides levels did not affect the risk of all-cause and CV death. The gray area identifies the 95% confidence intervals of estimated probabilities. Kidney International 2011 79, 765-772DOI: (10.1038/ki.2010.493) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 5 Estimated probabilities of all-cause and cardiovascular (CV) death associated with progressively higher values of serum cholesterol according to waist circumference tertiles. These probabilities were calculated by using the regression coefficients of Cox regression analyses, adjusting for all potential confounders (see legend to Figure 2). In these categorical analyses, progressively higher levels of cholesterol had opposite associations with clinical outcomes in the first (increasing risk at lower waist circumference) and in the third (increasing risk at higher waist circumference) tertile of waist circumference. In the middle waist circumference tertile, a progressive increase in cholesterol levels did not affect the risk of all-cause and CV death. The gray area identifies the 95% confidence intervals of estimated probabilities. Kidney International 2011 79, 765-772DOI: (10.1038/ki.2010.493) Copyright © 2011 International Society of Nephrology Terms and Conditions